Aptadel Therapeutics

🔬 Breaking Barriers in Biotech 💪♀️ In our lab, 5 out of 6 employees are women, 2 out of 3 in the C-level. We aren’t the exception - women in biotech are driving innovation every day. But despite our expertise and groundbreaking research, 💰 Did you know? · Startups with female founders receive less than 2% of VC funding. · Women-led biotech companies often face higher scrutiny and lower valuations than male-led counterparts. · Investors say they back the best ideas, but the data tells another story: unconscious bias is still at play. March 8th it’s a reminder that we still have work to do. If we want real progress, we need investors who fund based on potential, not outdated perceptions. To all the women in STEM: Keep breaking barriers. #WomenInSTEM #8M #internationalwomenday #EquityInScience #oncology #biotech #innovation #scientificresearch 

Childhood cancer is considered a #RareDisease Today, on Rare Disease Day we join organizations like ERDERA and FEDER ONG on the mission of advocating for more #research 🧪, improve #policies 📋and increase #investment 💰 #raredisease #rarebutmany #ewingsarcoma #pediatriccancer #RNAtherapeutics

Last week our CEO, Gisela Lorente, participated in the closing ceremony of #BCNHealthBooster accelerator 🚀 Thanks to Parc Científic de Barcelona Barcelona Activa Ajuntament de Barcelona and Biocat, BioRegion of Catalonia for supporting Aptadel for the last three years

Last week our CSO, Adrian Gabriel Torres PhD, presented Aptadel's latest developments in the framework of the #NPCFAnnualSummit in #Florida. Thanks to National Pediatric Cancer Foundation for the invitation and for your work supporting childhood cancer fighters and their families 💪 Learn more about the #SunshineProject: https://lnkd.in/du-sDUdG #RNAtherapeutics #childhoodcancer #personalizedoncology #aptamers

We are #hiring If you have 3+ years working in research laboratory environments and experience with xenograft mouse models, we want to meet you. Deadline: March 7th, 2025 Check the full offer below 👇

Today, on #WorldChildhoodCancerDay, we stand with brave young fighters and their families, raising awareness and supporting research for better treatments. While adult cancers receive the vast majority of investment, childhood cancers get only a fraction - despite being the leading cause of disease-related death in children.  Together, we can bring hope, care, and a better future for pediatric patients 💛🎗 #investinkid #cuttingedgescience #childhoodcancerday

We are proud to be #PCBCommunity

📣 This weekend La Vanguardia released a summary of our journey over the past four years, which also echoes our latest collaboration with Little Warrior Foundation.  Thanks Lorena Farràs Pérez for showcasing our work in Ewing sarcoma. #ewingsarcoma #pediatriconcology #RNAtherapies #aptamers #childhoodcancer #healthstartup #barcelonaecosystem Bellvitge Biomedical Research Institute - IDIBELL Oscar Martinez Tirado Gisela Lorente Adrian Gabriel Torres PhD Nadia Pons Jazmine Arévalo Laura Barbera Ferrando Laura López Molina, PhD

Today, on 🌍🎗#WorldCancerDay🎗🌍, we unite to raise awareness, show support, and push for meaningful change in the fight against cancer, especially in children. This day is a reminder of our #mission to #ChangeTheNarrative on how we treat cancer. With millions affected worldwide, today highlights the importance of #EarlyDetection, #GroundbreakingResearch, and ensuring #EquitableAccess to life-saving treatments. We reaffirm our commitment to: 🔬 Innovate with purpose 🤝 Collaborate with leading researchers & institutions 💡 Accelerate the development of life-saving treatments If you’re interested in learning more about our work, let’s connect! https://aptadeltx.com/ #WorldCancerDay #CloseTheCareGap #CancerResearch #RNATherapies #PediatricOncology #EwingSarcoma #Aptamers #ImpactResearch

🔝 What happened this January in the #BioRegion? Investments in startups, research breakthroughs, and strategic projects are strengthening Catalonia’s position as a global life sciences and healthcare hub. 📌 Monthly highlights: ✔️ Sycai Medical raises €3M to expand into the US. ✔️ DyCare - Digital Rehabilitation secures €1.2M through Capital Cell to boost its digital health solutions. ✔️ Heura Foods opens a new innovation lab in Barcelona’s 22@ district. ✔️ Peptomyc launches a Phase 2 clinical trial for osteosarcoma treatment. ✔️ vitalera obtains MDR Class IIa certification, paving the way for European expansion. ✔️ Aptadel Therapeutics partners with a U.S. foundation to advance its early-stage research. ✔️ Invivo Capital launches its third investment fund with a €20M deal in Neumirna Therapeutics. ✔️ Asabys Partners co-leads a €47.6M funding round for @Quibim. ✔️ Grifols secures a €281M contract with Spain’s Ministry of Health. ✔️ HIPRA launches HIPRA Biotech Services for contract development and manufacturing. ✔️ Oryzon Genomics SA ranks among Europe’s top 800 R&D investors. ✔️ SYNKOTECH BIOCOMPATIBLE MATERIALS SL opens its first production plant in Reus. ✔️ Biotecnología Bioeconómica announces a €12M investment in a new facility in Alcarràs. ✔️ Hospital Clínic de Barcelona leads an international study impacting liver cancer treatment. Want to dive deeper into this month’s highlights? Discover the picks of January here 👉 https://lnkd.in/dJse73AN